Evidence map›Paper›PMID 36038007›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2022

Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility.

González Daniel, Ayala-Ramírez Paola, Gelvez Nancy, Suarez-Obando Fernando, Ariza Beatriz, Ruiz Zulema, Arcila Julieth, Cardozo Claudia, Rojas Adriana

Open access · goldAbstract read
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Predictive Factors andInternational journal of molecular sciences · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

González DanielInstitute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Ayala-Ramírez PaolaInstitute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Gelvez NancyInstitute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Suarez-Obando FernandoInstitute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia.
Ariza BeatrizClinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.
Ruiz ZulemaClinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.
Arcila JuliethClinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.
Cardozo ClaudiaClinical Laboratory, Hospital Universitario San Ignacio, Bogotá, Colombia.
Rojas AdrianaInstitute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia. Electronic address: rojas-adriana@javeriana.edu.co.
Pontificia Universidad Javeriana · COHospital Universitario San Ignacio · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ACE2 protein acts as a gateway for SARS-CoV-2 in the host cell, playing an essential role in susceptibility to infection by this virus. Genetics and epigenetic mechanisms related to the ACE2 gene are associated with changes in its expression and, therefore, linked to increased susceptibility to infection. Although some variables such as sex, age, and obesity have been described as risk factors for COVID-19, the molecular causes involved in the disease susceptibility are still unknown.

aimTo evaluate the ACE2 gene expression profiles and their association with epigenetic mechanisms and demographic or clinical variables.

methodsIn 500 adult volunteers, the mRNA expression levels of the ACE2 gene in nasopharyngeal swab samples and its methylation status in peripheral blood samples were quantified by RT-qPCR and qMSP, respectively. The existence of significant differences in the ACE2 gene expression and its determinants were evaluated in different study groups according to several demographic or clinical variables such as sex, age, body mass index (BMI), smoking, SARS-CoV-2 infection, and presence of underlying diseases such as type II diabetes mellitus (DM2), asthma and arterial hypertension (AHT).

resultsOur results show that ACE2 gene overexpression, directly involved in susceptibility to SARS-CoV-2 infection, depends on multiple host factors such as male sex, age over 30 years, smoking, the presence of obesity, and DM2. Likewise, it was determined that the ACE2 gene expression is regulated by changes in the DNA methylation patterns in its promoter region.

conclusionsThe ACE2 gene expression is highly variable, and this variability is related to habits such as smoking and demographic or clinical variables, which details the impact of environmental and host factors on our epigenome and, therefore, in susceptibility to SARS-CoV-2 infection.

Indexed as

COVID-19Diabetes Mellitus, Type 2AdultAngiotensin-Converting Enzyme 2Epigenesis, GeneticGene ExpressionHumansMaleObesityRNA, MessengerSARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2RNA, MessengerAngiotensin-converting enzyme 2COVID-19Disease susceptibilityEpigeneticsHost factorsSARS-CoV-2

Identifiers

PMID36038007
PMCPMC9420046
OpenAlexW4293681076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.